Harrow Health, Inc. (HROW) key performance indicators and operating metrics (7 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Gross Margin | 61.00 percent | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization | 24.2M | FY2025-Q4 |
| Core Gross Margin | 81.00 percent | FY2025-Q3 |
| Core Basic Net Loss Per Share | 0.35 USD_per_share | FY2025-Q3 |
| Core Diluted Net Loss Per Share | 0.33 USD_per_share | FY2025-Q3 |
| Core Net Income | 9.22M | FY2025-Q2 |
| Core Net Loss Per Share | -0.38 USD_per_share | FY2025-Q1 |
Back to HROW overview · HROW earnings · HROW holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.